Dysprealbuminemic hyperthyroxinemia in a patient with hyperthyroid graves disease

Scott J. Cameron, Judith C. Hagedorn, Lori J Sokoll, Patrizio P Caturegli, Paul W Ladenson

Research output: Contribution to journalArticle

Abstract

Rare mutant forms of circulating albumin and prealbumin [transthyretin (TTR)] have increased binding affinity for thyroxine (T 4). Patients with these variant plasma proteins, as a result of inherited mutations or as a paraneoplastic phenomenon, typically present with increased serum total T 4 and, by some assay methodologies, an increased free T 4 as well. Although these individuals are, in fact, euthyroid, nonspecific symptoms may lead to inappropriate treatment for hyperthyroidism. We present a 34-year-old woman in whom a mutant form of TTR with increased T 4 binding affinity and coexisting Graves disease was present. Subsequent 131I therapy led to development of postablative hypothyroidism, which was obscured by her higher serum free T 4 concentration. Circulating thyroid-binding globulin (TBG), albumin, and TTR concentrations were all within their respective reference limits. A T 4-binding protein panel confirmed that TTR-bound T 4 was significantly increased, whereas TBG- and albumin-bound T 4 was normal, indicating that this patient had euthyroid dysprealbuminemic hyperthyroxinemia, which had been masked by the initial presentation of hyperthyroidism. These findings indicate that hypothyroidism can be masked by coexisting euthyroid dysprealbuminemic hyperthyroxinemia.

Original languageEnglish (US)
Pages (from-to)1065-1069
Number of pages5
JournalClinical Chemistry
Volume51
Issue number6
DOIs
StatePublished - Jun 2005

Fingerprint

Prealbumin
Graves Disease
Hyperthyroidism
Albumins
Globulins
Hypothyroidism
Thyroid Gland
Serum
Thyroxine
Blood Proteins
Assays
Carrier Proteins
Dystransthyretinemic Euthyroidal Hyperthyroxinemia
Mutation
Therapeutics

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

Dysprealbuminemic hyperthyroxinemia in a patient with hyperthyroid graves disease. / Cameron, Scott J.; Hagedorn, Judith C.; Sokoll, Lori J; Caturegli, Patrizio P; Ladenson, Paul W.

In: Clinical Chemistry, Vol. 51, No. 6, 06.2005, p. 1065-1069.

Research output: Contribution to journalArticle

@article{db13ce04f2ca4312ba36a16f142be377,
title = "Dysprealbuminemic hyperthyroxinemia in a patient with hyperthyroid graves disease",
abstract = "Rare mutant forms of circulating albumin and prealbumin [transthyretin (TTR)] have increased binding affinity for thyroxine (T 4). Patients with these variant plasma proteins, as a result of inherited mutations or as a paraneoplastic phenomenon, typically present with increased serum total T 4 and, by some assay methodologies, an increased free T 4 as well. Although these individuals are, in fact, euthyroid, nonspecific symptoms may lead to inappropriate treatment for hyperthyroidism. We present a 34-year-old woman in whom a mutant form of TTR with increased T 4 binding affinity and coexisting Graves disease was present. Subsequent 131I therapy led to development of postablative hypothyroidism, which was obscured by her higher serum free T 4 concentration. Circulating thyroid-binding globulin (TBG), albumin, and TTR concentrations were all within their respective reference limits. A T 4-binding protein panel confirmed that TTR-bound T 4 was significantly increased, whereas TBG- and albumin-bound T 4 was normal, indicating that this patient had euthyroid dysprealbuminemic hyperthyroxinemia, which had been masked by the initial presentation of hyperthyroidism. These findings indicate that hypothyroidism can be masked by coexisting euthyroid dysprealbuminemic hyperthyroxinemia.",
author = "Cameron, {Scott J.} and Hagedorn, {Judith C.} and Sokoll, {Lori J} and Caturegli, {Patrizio P} and Ladenson, {Paul W}",
year = "2005",
month = "6",
doi = "10.1373/clinchem.2005.050518",
language = "English (US)",
volume = "51",
pages = "1065--1069",
journal = "Clinical Chemistry",
issn = "0009-9147",
publisher = "American Association for Clinical Chemistry Inc.",
number = "6",

}

TY - JOUR

T1 - Dysprealbuminemic hyperthyroxinemia in a patient with hyperthyroid graves disease

AU - Cameron, Scott J.

AU - Hagedorn, Judith C.

AU - Sokoll, Lori J

AU - Caturegli, Patrizio P

AU - Ladenson, Paul W

PY - 2005/6

Y1 - 2005/6

N2 - Rare mutant forms of circulating albumin and prealbumin [transthyretin (TTR)] have increased binding affinity for thyroxine (T 4). Patients with these variant plasma proteins, as a result of inherited mutations or as a paraneoplastic phenomenon, typically present with increased serum total T 4 and, by some assay methodologies, an increased free T 4 as well. Although these individuals are, in fact, euthyroid, nonspecific symptoms may lead to inappropriate treatment for hyperthyroidism. We present a 34-year-old woman in whom a mutant form of TTR with increased T 4 binding affinity and coexisting Graves disease was present. Subsequent 131I therapy led to development of postablative hypothyroidism, which was obscured by her higher serum free T 4 concentration. Circulating thyroid-binding globulin (TBG), albumin, and TTR concentrations were all within their respective reference limits. A T 4-binding protein panel confirmed that TTR-bound T 4 was significantly increased, whereas TBG- and albumin-bound T 4 was normal, indicating that this patient had euthyroid dysprealbuminemic hyperthyroxinemia, which had been masked by the initial presentation of hyperthyroidism. These findings indicate that hypothyroidism can be masked by coexisting euthyroid dysprealbuminemic hyperthyroxinemia.

AB - Rare mutant forms of circulating albumin and prealbumin [transthyretin (TTR)] have increased binding affinity for thyroxine (T 4). Patients with these variant plasma proteins, as a result of inherited mutations or as a paraneoplastic phenomenon, typically present with increased serum total T 4 and, by some assay methodologies, an increased free T 4 as well. Although these individuals are, in fact, euthyroid, nonspecific symptoms may lead to inappropriate treatment for hyperthyroidism. We present a 34-year-old woman in whom a mutant form of TTR with increased T 4 binding affinity and coexisting Graves disease was present. Subsequent 131I therapy led to development of postablative hypothyroidism, which was obscured by her higher serum free T 4 concentration. Circulating thyroid-binding globulin (TBG), albumin, and TTR concentrations were all within their respective reference limits. A T 4-binding protein panel confirmed that TTR-bound T 4 was significantly increased, whereas TBG- and albumin-bound T 4 was normal, indicating that this patient had euthyroid dysprealbuminemic hyperthyroxinemia, which had been masked by the initial presentation of hyperthyroidism. These findings indicate that hypothyroidism can be masked by coexisting euthyroid dysprealbuminemic hyperthyroxinemia.

UR - http://www.scopus.com/inward/record.url?scp=19644390653&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=19644390653&partnerID=8YFLogxK

U2 - 10.1373/clinchem.2005.050518

DO - 10.1373/clinchem.2005.050518

M3 - Article

C2 - 15833783

AN - SCOPUS:19644390653

VL - 51

SP - 1065

EP - 1069

JO - Clinical Chemistry

JF - Clinical Chemistry

SN - 0009-9147

IS - 6

ER -